Trace Element Replenishment Study in Hemodialysis Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT01473914
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01473914
-
- Main results
- Trace element supplementation in hemodialysis patients: a randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01473914. Randomized; quadruple masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trace Element Replenishment Study in Hemodialysis Patients
- Condition
- End Stage Renal Disease
- Intervention (Dietary supplement)
- Low dose: supplemental zinc, selenium and vitamin E
- Intervention (Dietary supplement)
- Standard renal vitamin: B and C renal vitamin
- Intervention (Dietary supplement)
- Medium dose: supplemental zinc, selenium and vitamin E
- Lead sponsor
- Marcello Tonelli
- Collaborator
- Alberta Health services
Record details
- Record id
cardio:ct-nct01473914- Content hash
5537107ff12658da7fee2ee214414ac4e2108e85f12d96645cd7a5c562a0eee3